The Costco GLP-1 CPG Brand Opportunity 2026: How to Position, Formulate and Pitch for the Fastest-Growing Health Category

alexsteinbergmojo
2 days ago
10 min read

Anything protein right now is doing extremely well, Costco CFO Gary Millerchip told investors during the retailer's Q3 2026 earnings call. He was explaining the specific commercial dynamic that GLP-1 weight loss medications — Ozempic, Wegovy, Zepbound, Mounjaro — have created in the Costco member demographic.

The data behind that observation communicates the scale of the commercial opportunity with specificity. The number of Americans taking GLP-1 medications more than doubled to 12.4 percent compared with 5.8 percent in February 2024. Approximately 15 to 20 million Americans are now using GLP-1 medications for weight management in 2026 — and they are actively and systematically changing their food purchasing behavior in ways that create specific commercial opportunities for CPG brands positioned to serve their nutritional needs.

The GLP-1 consumer's food behavior transformation is documented precisely. 61 percent of current GLP-1 users say they are buying fewer sweet treats. 56 percent say the same about salty snacks. In their place: 44 percent are buying more fresh produce, 35 percent more packaged protein, and 34 percent more fresh protein. An estimated $6.5 billion in U.S. grocery sales has been lost due to reduced snacking among GLP-1 users — and the brands best positioned to capture the spending that is shifting from reduced-calorie snacking toward protein-dense, nutrient-optimized foods are the brands that move fastest.

For CPG brands in the Costco channel, this is not an abstract market trend. It is a specific, buyer-verified commercial opportunity that Costco's own institutional response has validated: Kirkland Signature Beef Sticks are doing tremendous volume per the CFO. Kirkland Signature Ultra Filtered Protein Milk has just taken off per the CEO. The buying team that is watching these Kirkland Signature items generate exceptional velocity is simultaneously receptive to branded CPG alternatives in the GLP-1-adjacent nutrition space — if the brand's positioning is credible, the nutritional profile is genuinely aligned with GLP-1 user needs, and the commercial pitch communicates the specific member value proposition rather than the general health trend language that most health and wellness pitches default to.

This guide provides the complete CPG brand strategy for the Costco GLP-1 opportunity in 2026 — the consumer behavior data that frames the market, the nutritional formulation standards that GLP-1-aligned products must meet, the positioning framework that communicates credibly to the buyer, and the buyer pitch structure that converts the GLP-1 opportunity into a purchase order.

The GLP-1 Consumer: Understanding Who You Are Designing For

The Nutritional Reality of GLP-1 Use

GLP-1 medications work by slowing gastric emptying and reducing appetite — producing the significant reduction in total daily caloric intake that drives weight loss. The typical GLP-1 user consumes meaningfully fewer calories per day than before medication — which creates a specific nutritional challenge: consuming fewer calories while maintaining adequate protein intake, adequate fiber intake, and adequate micronutrient consumption to prevent the muscle loss, digestive disruption, and nutritional deficiencies that significant caloric restriction without nutritional awareness produces.

The nutritional priorities that GLP-1 users — and their registered dietitian advisors — consistently identify as the most important:

Protein adequacy. GLP-1 medications reduce total food volume significantly — making it specifically difficult for users to consume adequate protein from whole food sources alone.

The standard recommendation for GLP-1 users is 1.2 to 1.5 grams of protein per kilogram of body weight per day — an intake level that a significantly reduced caloric diet makes difficult to achieve without specifically prioritizing protein density in every eating occasion. Products that deliver high protein density per calorie, per serving, or per bite are the specific functional priority that GLP-1 users are actively seeking.

Fiber adequacy. GLP-1 medications can cause constipation as a side effect — because the slowed gastric motility that reduces appetite simultaneously reduces digestive transit. Fiber-enriched products that support digestive regularity are the specific functional addition that many GLP-1 users seek to address this side effect.

Micronutrient density. Eating significantly less total food means consuming significantly fewer total micronutrients — unless the reduced food volume is specifically selected for micronutrient density. Products fortified with iron, B vitamins, calcium, magnesium, and zinc address the specific micronutrient gap that significant caloric restriction creates.

Smaller portion formats. GLP-1 users describe a specific eating experience: rapid satiety at low food volume, discomfort from traditional large serving sizes, and a preference for smaller, more frequent eating occasions rather than the conventional three-meal-per-day structure. Products in smaller serving formats — or products that communicate a portion-appropriate serving size that aligns with the reduced appetite reality — are specifically more usable for this consumer than conventional large-serving formats.

The Market Opportunity: Why Costco Is the Right Channel for GLP-1-Adjacent Brands

The Costco Member Demographic and GLP-1 Prevalence

The Costco member demographic is specifically over-indexed for GLP-1 medication use — because the demographic characteristics that correlate with GLP-1 prescription access (higher household income, private insurance coverage, proximity to healthcare providers) are also the demographic characteristics that define the Costco member base.

GLP-1 medications in 2026 are expensive — with out-of-pocket costs ranging from $300 to $1,000+ per month without insurance coverage, and insurance coverage that varies significantly by plan and by indication. The GLP-1 user in 2026 is disproportionately a higher-income adult with private insurance access — exactly the Costco member demographic.

The percentage of Costco members using GLP-1 medications is meaningfully above the 12.4 percent national average.

This demographic concentration creates a specific commercial opportunity: the product positioned for GLP-1 companion nutrition at Costco is reaching a higher-concentration GLP-1 user audience than the same product would reach in a conventional grocery store — because the Costco member base over-indexes for exactly the income and insurance demographic that GLP-1 medication access requires.

Costco's Institutional Validation of the Category

Costco's own institutional response to the GLP-1 opportunity validates the commercial thesis directly:

The Kirkland Signature Beef Sticks launch — high protein, portable, low carbohydrate — is described by the CFO as doing tremendous volume. This is not a niche performance; it is a mainstream institutional velocity that communicates the GLP-1-influenced Costco member's protein priority is operating at warehouse-scale.

The Kirkland Signature Ultra Filtered Protein Milk — 13 grams of protein per 8-ounce serving, lactose reduced, at institutional pricing — is described by the CEO as having just taken off. This is a product that did not exist as a mainstream warehouse item before the GLP-1 era. Its institutional success communicates the buying team's active awareness of and enthusiasm for protein-dense products that serve the GLP-1 member demographic.

The Kirkland Signature GLP-1 prescription access through the pharmacy program — Wegovy and Ozempic available at Costco's institutional pharmacy pricing with GoodRx discounts — communicates that Costco is not passively observing the GLP-1 opportunity. It is actively building institutional relationships that deepen the warehouse's connection to the GLP-1 consumer segment.

For CPG brands, this institutional validation communicates something specific: the Costco buying team has seen the GLP-1 data, has made their own institutional bets on protein and nutrient density, and is receptive to branded CPG alternatives that credibly serve the same nutritional need in product categories where Kirkland has not yet established dominance.

The Formulation Standards: What GLP-1-Aligned Products Must Deliver

The GLP-1 companion nutrition claim — implicit or explicit — requires a product formulation that genuinely addresses the nutritional priorities the GLP-1 user's situation creates. The brands that attempt to position existing products as GLP-1-friendly without genuine nutritional alignment will find the claim unconvincing to both the buyer and the consumer.

The formulation standards that define genuine GLP-1 alignment:

Protein density minimum: 15 grams of protein per serving as the minimum threshold for a product that credibly claims high-protein positioning for GLP-1 users. Products with 8 to 10 grams of protein per serving are not meaningfully protein-dense in the GLP-1 context — they are conventionally protein-containing. 20 to 30+ grams per serving is the range that communicates genuinely high protein density to the GLP-1 user whose protein intake challenge is real and significant.

Calorie-to-protein ratio: the protein density metric that most directly communicates GLP-1 alignment is grams of protein per 100 calories. The GLP-1 user who is eating fewer calories needs the highest possible protein per calorie consumed. A product delivering 10 grams of protein per 100 calories (the whey protein isolate standard) is meaningfully more GLP-1-aligned than a product delivering 4 grams per 100 calories (a typical snack bar standard).

Fiber content: a minimum of 5 grams of dietary fiber per serving for products making a fiber claim that addresses GLP-1's constipation side effect. The fiber type also matters: soluble fiber (beta-glucan, inulin, psyllium) is specifically more effective for the constipation concern than insoluble fiber — and products that communicate the specific fiber type and its digestive benefit communicate more credibly to the GLP-1 user than generic fiber content claims.

Serving size alignment: the conventional large serving format — a 400-calorie protein shake, a 50-gram protein bar — may be appropriate for the strength-training consumer who is managing high caloric intake. For the GLP-1 user experiencing rapid satiety at reduced food volume, the 200 to 250 calorie serving size that delivers 20+ grams of protein is the format that aligns with the actual eating occasion reality.

Ingredient transparency: the GLP-1 consumer who is making deliberate nutritional choices — and who is managing medication side effects through food selection — is a consumer who reads ingredient labels carefully. Artificial sweeteners, added sugars, and complex additive lists are specifically concerning to this consumer. Clean ingredient formulations — minimal processing, recognizable ingredients, no artificial sweeteners in the products where natural alternatives are available — communicate the nutritional intelligence that the GLP-1-aware buyer expects.

The Positioning Framework: How to Communicate Without Over-Claiming

The GLP-1 companion nutrition positioning challenge is specific: the brand wants to communicate that the product serves the nutritional needs of GLP-1 users without making drug claim adjacency that the FDA's food and drug interface rules limit.

A food product cannot claim to "treat," "cure," "mitigate," or "prevent" any health condition — including obesity, the condition that GLP-1 medications are prescribed to treat. A food product can make structure/function claims (nutrient content claims, health claims) that communicate the nutritional characteristics that GLP-1 users specifically need without referencing the medication or its indications.

Positioning language that communicates GLP-1 alignment without making drug adjacency claims:

High protein positioning: "27 grams of protein per serving — the protein your body needs, in less food." This communicates the protein density and the smaller-volume eating occasion that GLP-1 users experience without mentioning GLP-1 or weight loss medication.

Satiety and nutrient density: "High protein + 5g fiber + essential vitamins — built for the times when every bite counts." This communicates the specific nutritional priorities that GLP-1 users identify as most important without making any drug or disease claims.

Muscle preservation: "Protein for muscle maintenance during weight management." This health claim — supported by the FDA's authorized health claim framework for protein and muscle maintenance — communicates the specific GLP-1 user concern of muscle loss during significant caloric restriction.

The Buyer Pitch Framework: Presenting the GLP-1 Opportunity to Costco's Buying Team

The buyer pitch that communicates the GLP-1 opportunity most effectively to the Costco buying team combines four elements:

The market data presentation: the specific consumer behavior data that frames the commercial opportunity. The 12.4 percent GLP-1 prevalence figure, the $6.5 billion in snack sales lost to GLP-1 behavioral change, the CFO's specific statement that "anything protein right now is doing extremely well," and the PwC survey data showing 35 percent of GLP-1 users buying more packaged protein. This data does not tell the buyer something they do not know — it frames the shared commercial reality in a way that establishes the pitch's analytical credibility.

The Costco member demographic GLP-1 concentration argument: the specific reason why the GLP-1 opportunity is more commercially significant at Costco than at conventional grocery retail. The income and insurance demographic correlation means the Costco member base over-indexes for GLP-1 users — making every unit of shelf space dedicated to GLP-1-aligned nutrition more commercially productive at Costco than at a general grocery channel.

The product's specific nutritional alignment: the protein per serving, the calorie-to-protein ratio, the fiber content, and the serving size format that communicates genuine GLP-1 alignment rather than generic health positioning. This is the element that distinguishes a credible GLP-1 companion nutrition pitch from a generic "better for you" pitch — and it is the element that the buyer who has been watching Kirkland Signature beef sticks and protein milk succeed will evaluate most carefully.

The velocity projection built on comparable product performance: the roadshow velocity expectations based on comparable high-protein products at Costco. The Kirkland Signature beef sticks velocity data — shared in the earnings call as "doing tremendous volume" — is the category benchmark that the branded CPG alternative must credibly project against. The brand that can show category velocity data for comparable high-protein products at Costco, and can project how their roadshow execution will generate comparable or superior velocity, is making the commercial case in the terms the buyer uses to evaluate commercial risk.

The Brands Winning the GLP-1 Category at Costco in 2026

The CPG brands most actively capturing the GLP-1 companion nutrition opportunity at Costco and comparable channels in 2026 include Nestlé (GLP-1-specific product lines under development), Conagra, Danone, and Nissin — each moving to develop products specifically formulated for the reduced-appetite, high-nutrient-density needs of the GLP-1 user population.

For emerging and mid-size CPG brands, this institutional movement by the large CPG companies communicates both the commercial validation of the category and the urgency of moving quickly — because the window where emerging brands can establish category position before the institutional CPG giants dominate the assortment is a finite one.

The specific product categories where emerging CPG brands retain competitive positioning in the GLP-1 space despite large-CPG competition:

Functional protein snacks with clean ingredient formulations that institutional brands' production constraints make difficult to deliver. The emerging brand that can deliver 25+ grams of protein per serving in a clean-ingredient, real-food format has a formulation differentiation that Nestlé's institutional production scale cannot easily replicate.

Mission-driven supplement brands with clinical credentialing specific to their formulation — the probiotic strain research, the specific protein source bioavailability study, the registered dietitian partnership — that creates the credibility gap that institutional brands cannot close through scale alone.

Specialty dietary format proteins — grass-fed whey, plant-based complete protein, collagen protein — that serve the GLP-1 user who has specific ingredient preferences beyond the commodity whey protein isolate that Kirkland Signature and institutional brands default to.

At Fractional Brand Managers, we help CPG brands develop the GLP-1 companion nutrition positioning strategy, formulate the product profile against the nutritional benchmarks that Costco's buying team is validating in real-time, and build the buyer pitch that connects the brand's specific nutritional credentials to the fastest-growing health and wellness opportunity in the warehouse.

Costco GLP-1 CPG Opportunity 2026 — Complete Framework:

Element	Specifics	Why It Matters
Market size	15-20M GLP-1 users; 12.4% of Americans	Over-indexed in Costco's higher-income member demographic
Consumer behavior shift	-61% sweet treats, -56% salty snacks, +35% packaged protein	$6.5B snack sales lost → redirected to protein/fiber
Costco validation	Kirkland beef sticks "tremendous volume," protein milk "just took off"	Buyer team confirmed the demand signal institutionally
Protein threshold	15g minimum; 20-30g+ optimal; 10g+ per 100 calories	The nutritional density that GLP-1 users specifically need
Fiber standard	5g+ soluble fiber for digestive support	Addresses constipation side effect — specific GLP-1 priority
Serving size	200-250 calorie format aligned to reduced appetite reality	Conventional large servings misaligned with GLP-1 eating occasion
Positioning language	Structure/function claims — never drug adjacency	FDA food/drug interface rules limit GLP-1-specific claims
Buyer pitch elements	Market data + Costco demo over-index + nutritional alignment + velocity projection	The four-element framework that earns buyer credibility